The author’s views are entirely his or her own (excluding the unlikely event of hypnosis) and may not always reflect the views of Moz. Typically, […]
Tag: Advanced
Novartis radioligand therapy Pluvicto gets approval in EU for advanced prostate cancer
artJazz The European Commission (EC) approved Novartis (NYSE:NVS) Pluvicto to treat certain patients with advanced prostate cancer. The radioligand therapy was approved in combination with […]